» Articles » PMID: 23217101

The Group A Streptococcal Collagen-like Protein-1, Scl1, Mediates Biofilm Formation by Targeting the Extra Domain A-containing Variant of Cellular Fibronectin Expressed in Wounded Tissue

Overview
Journal Mol Microbiol
Date 2012 Dec 11
PMID 23217101
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Wounds are known to serve as portals of entry for group A Streptococcus (GAS). Subsequent tissue colonization is mediated by interactions between GAS surface proteins and host extracellular matrix components. We recently reported that the streptococcal collagen-like protein-1, Scl1, selectively binds the cellular form of fibronectin (cFn) and also contributes to GAS biofilm formation on abiotic surfaces. One structural feature of cFn, which is predominantly expressed in response to tissue injury, is the presence of a spliced variant containing extra domain A (EDA/EIIIA). We now report that GAS biofilm formation is mediated by the Scl1 interaction with EDA-containing cFn. Recombinant Scl1 proteins that bound cFn also bound recombinant EDA within the C-C' loop region recognized by the α(9)β(1) integrin. The extracellular 2-D matrix derived from human dermal fibroblasts supports GAS adherence and biofilm formation. Altogether, this work identifies and characterizes a novel molecular mechanism by which GAS utilizes Scl1 to specifically target an extracellular matrix component that is predominantly expressed at the site of injury in order to secure host tissue colonization.

Citing Articles

Group A streptococcal collagen-like protein 1 restricts tumor growth in murine pancreatic adenocarcinoma and inhibits cancer-promoting neutrophil extracellular traps.

Henderson E, Ivey A, Choi S, Santiago S, McNitt D, Liu T Front Immunol. 2024; 15:1363962.

PMID: 38515758 PMC: 10955053. DOI: 10.3389/fimmu.2024.1363962.


Group A Streptococcal Collagen-like Protein 1 Restricts Tumor Growth in Murine Pancreatic Adenocarcinoma and Inhibits Cancer-Promoting Neutrophil Extracellular Traps.

Henderson E, Ivey A, Choi S, Santiago S, McNitt D, Liu T bioRxiv. 2024; .

PMID: 38293049 PMC: 10827155. DOI: 10.1101/2024.01.17.576060.


Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer.

Henderson E, Lukomski S, Boone B Front Oncol. 2023; 13:1217095.

PMID: 37588093 PMC: 10425600. DOI: 10.3389/fonc.2023.1217095.


Prokaryotic Collagen-Like Proteins as Novel Biomaterials.

Picker J, Lan Z, Arora S, Green M, Hahn M, Cosgriff-Hernandez E Front Bioeng Biotechnol. 2022; 10:840939.

PMID: 35372322 PMC: 8968730. DOI: 10.3389/fbioe.2022.840939.


A narrative review of long noncoding RNA: insight into neural ischemia/reperfusion mediated by two pathophysiological processes of injury and repair.

Cai L, Zhang B Ann Transl Med. 2022; 10(4):235.

PMID: 35280354 PMC: 8908171. DOI: 10.21037/atm-22-268.


References
1.
Rasmussen M, Bjorck L . Unique regulation of SclB - a novel collagen-like surface protein of Streptococcus pyogenes. Mol Microbiol. 2001; 40(6):1427-38. DOI: 10.1046/j.1365-2958.2001.02493.x. View

2.
To W, Midwood K . Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair. 2011; 4:21. PMC: 3182887. DOI: 10.1186/1755-1536-4-21. View

3.
Humtsoe J, Kim J, Xu Y, Keene D, Hook M, Lukomski S . A streptococcal collagen-like protein interacts with the alpha2beta1 integrin and induces intracellular signaling. J Biol Chem. 2005; 280(14):13848-57. DOI: 10.1074/jbc.M410605200. View

4.
Kim J, Singvall J, Schwarz-Linek U, Johnson B, Potts J, Hook M . BBK32, a fibronectin binding MSCRAMM from Borrelia burgdorferi, contains a disordered region that undergoes a conformational change on ligand binding. J Biol Chem. 2004; 279(40):41706-14. DOI: 10.1074/jbc.M401691200. View

5.
Cramer T, Yamanishi Y, Clausen B, Forster I, Pawlinski R, Mackman N . HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell. 2003; 112(5):645-57. PMC: 4480774. DOI: 10.1016/s0092-8674(03)00154-5. View